DE69500490T2 - Glattmuskelrelaxierende Arzneizubereitungen - Google Patents

Glattmuskelrelaxierende Arzneizubereitungen

Info

Publication number
DE69500490T2
DE69500490T2 DE69500490T DE69500490T DE69500490T2 DE 69500490 T2 DE69500490 T2 DE 69500490T2 DE 69500490 T DE69500490 T DE 69500490T DE 69500490 T DE69500490 T DE 69500490T DE 69500490 T2 DE69500490 T2 DE 69500490T2
Authority
DE
Germany
Prior art keywords
smooth muscle
medicinal preparations
relax smooth
tryptophan
serine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69500490T
Other languages
English (en)
Other versions
DE69500490D1 (de
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polichem SA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69500490(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Application granted granted Critical
Publication of DE69500490D1 publication Critical patent/DE69500490D1/de
Publication of DE69500490T2 publication Critical patent/DE69500490T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69500490T 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen Expired - Lifetime DE69500490T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (2)

Publication Number Publication Date
DE69500490D1 DE69500490D1 (de) 1997-09-04
DE69500490T2 true DE69500490T2 (de) 1997-12-04

Family

ID=11369756

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0707853T Pending DE707853T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen
DE69500490T Expired - Lifetime DE69500490T2 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0707853T Pending DE707853T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende Arzneizubereitungen

Country Status (9)

Country Link
EP (1) EP0707853B1 (de)
AT (1) ATE156016T1 (de)
CA (1) CA2160938C (de)
DE (2) DE707853T1 (de)
DK (1) DK0707853T3 (de)
ES (1) ES2088379T3 (de)
GR (2) GR960300039T1 (de)
HK (1) HK1001719A1 (de)
IT (1) IT1271031B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779889B2 (en) * 1999-12-22 2005-02-17 Glaxo Group Limited Methods for preparing pharmaceutical formulations
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
EP2007355A2 (de) * 2005-12-08 2008-12-31 Wyeth a Corporation of the State of Delaware Liposomale zusammensetzungen
EP2712611A1 (de) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675930B2 (en) * 1992-02-18 1997-02-27 Pharmos Corp. Dry compositions for preparing submicron emulsions
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
DE707853T1 (de) 1996-12-12
ITMI942166A0 (it) 1994-10-21
HK1001719A1 (en) 1998-07-03
DK0707853T3 (da) 1998-03-02
ITMI942166A1 (it) 1996-04-21
CA2160938C (en) 2008-07-15
ES2088379T3 (es) 1997-10-16
IT1271031B (it) 1997-05-26
EP0707853A1 (de) 1996-04-24
GR3024761T3 (en) 1997-12-31
EP0707853B1 (de) 1997-07-30
ATE156016T1 (de) 1997-08-15
GR960300039T1 (en) 1996-08-31
DE69500490D1 (de) 1997-09-04
ES2088379T1 (es) 1996-08-16
CA2160938A1 (en) 1996-04-22

Similar Documents

Publication Publication Date Title
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
PT792287E (pt) Analogos peptidicos da proteina basica da mielina humana
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
HK1039271A1 (en) Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology.
DE69614681D1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
ATE358684T1 (de) Waessrige formulierung enthaltend tfpi und lösungsvermittlers
DE69500490T2 (de) Glattmuskelrelaxierende Arzneizubereitungen
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
ES2121940T3 (es) Composiciones antitumorales y procedimientos de tratamiento.
ATE201693T1 (de) Hämoregulierende peptide
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
YU20050685A (sh) Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
KR970073601A (ko) 생리 활성 펩티드 함유 경비 투여용 조성물
FI942938A0 (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
SE9901773D0 (sv) Förebyggande av karies i tänderna
SE0002232D0 (sv) Antioxidant
KR970701559A (ko) 펩타이드의 경구 투여를 위한 안정화된 조성물(stabilized composition for oral administration of peptides)
BR0313432A (pt) Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos
IT1254191B (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: POLICHEM S.A., LUXEMBURG/LUXEMBOURG, LU